Literature DB >> 6822418

Hyperthermic enhancement of serum antimicrobial activity: mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis.

P A Mackowiak, M Marling-Cason.   

Abstract

We have previously demonstrated heightened antibiotic activity at temperatures at the upper end of the physiological range. In the present studies we examined the effect of physiological variations in temperature on the antibacterial activity of antibiotic-free pooled human serum by comparing serum minimal inhibitory and bactericidal titers for gram-positive and gram-negative bacterial strains at 33, 37, and 41 degrees C. We observed a progressive rise in both minimal inhibitory and minimal bactericidal titers with temperature for all classes of gram-negative bacilli studied. However, gram-positive cocci were generally resistant to serum, even at the highest experimental temperature. Bacterial strains adapted to growth at temperatures normally encountered on body surfaces were more susceptible to the enhancing effect of hyperthermia on serum inhibition than were strains adapted to 37 degrees C. In addition, in vitro adaptation of one bacterial strain to different temperatures within the physiological range resulted in readily apparent variations in colonial morphology. These in vitro observations indicate that serum antibacterial activity and bacterial morphology may vary in response to minor changes in either the temperature to which bacteria are adapted before examination or the temperature of the assay system. If similar principles operate in vivo, hyperthermically augmented serum antimicrobial activity might represent one mechanism by which fever exerts a beneficial effect on the outcome of gram-negative sepsis.

Entities:  

Mesh:

Year:  1983        PMID: 6822418      PMCID: PMC347904          DOI: 10.1128/iai.39.1.38-42.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Bactericidal activity of normal serum against bacterial cultures. I. Activity against Salmonella typhi strains.

Authors:  L H MUSCHEL; R H CHAMBERLIN; E OSAWA
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

2.  [Antigens impeding the action of certain bacteriophages].

Authors:  P NICOLLE; A JUDE; G DIVERNEAU
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-01

Review 3.  Temperature and host defense.

Authors:  N J Roberts
Journal:  Microbiol Rev       Date:  1979-06

4.  Factors affecting mortality of gram-negative rod bacteremia.

Authors:  R E Bryant; A F Hood; C E Hood; M G Koenig
Journal:  Arch Intern Med       Date:  1971-01

5.  Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis.

Authors:  M P Weinstein; P B Iannini; C W Stratton; T C Eickhoff
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

6.  Effects of storage of blood on stability of hematologic parameters.

Authors:  S D Cohle; A Saleem; D E Makkaoui
Journal:  Am J Clin Pathol       Date:  1981-07       Impact factor: 2.493

Review 7.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

8.  Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.

Authors:  G L Simon; M S Klempner; D L Kasper; S L Gorbach
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

9.  Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.

Authors:  L H Muschel; L A Ahl; M W Fisher
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

10.  Polymicrobial sepsis: an analysis of 184 cases using log linear models.

Authors:  P A Mackowiak; R H Browne; P M Southern; J W Smith
Journal:  Am J Med Sci       Date:  1980 Sep-Oct       Impact factor: 2.378

View more
  7 in total

1.  Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection.

Authors:  Moshe Giladi; Yaara Porat; Alexandra Blatt; Esther Shmueli; Yoram Wasserman; Eilon D Kirson; Yoram Palti
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  Targeted antibiotic delivery using low temperature-sensitive liposomes and magnetic resonance-guided high-intensity focused ultrasound hyperthermia.

Authors:  Rachel Wardlow; Chenchen Bing; Joshua VanOsdol; Danny Maples; Michelle Ladouceur-Wodzak; Michele Harbeson; Joris Nofiele; Robert Staruch; Akhilesh Ramachandran; Jerry Malayer; Rajiv Chopra; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2016-02-18       Impact factor: 3.914

Review 3.  Treatment of fever in childhood.

Authors:  D Adam; G Stankov
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

4.  Differential acute-phase responses in febrile and cold- and heat-exposed rabbits.

Authors:  T A Mashburn; J Llanos; W S Hunter; R A Ahokas; C M Blatteis
Journal:  Pflugers Arch       Date:  1984-10       Impact factor: 3.657

Review 5.  Fever: Views in Anthroposophic Medicine and Their Scientific Validity.

Authors:  David D Martin
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-24       Impact factor: 2.629

6.  Warming up for a better fever: a randomized pilot study in pediatric oncology.

Authors:  Hanno S Krafft; Christa K Raak; Ekkehart Jenetzky; Tycho J Zuzak; Alfred Längler; David D Martin
Journal:  Pilot Feasibility Stud       Date:  2022-08-16

7.  Adjuvant Transgingival Therapy with Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) in Periodontal Therapy-A Randomized, Controlled, Stratified, Double-Blinded Clinical Trial.

Authors:  Stefanie Anna Peikert; Anil Fischer; Anne Brigitte Kruse; Ali Al-Ahmad; Johan Peter Woelber; Kirstin Vach; Andreas Braun; Petra Ratka-Krüger
Journal:  Antibiotics (Basel)       Date:  2021-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.